Real-time enrollment status for this kidney cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:10 AM UTC
| NCT Number | NCT04620239 |
| Recruiting Status | Recruiting |
| Condition | Kidney Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Steba Biotech S.A. |
| Last Updated on CT.gov | February 4, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT04620239 is currently recruiting participants. This clinical trial study for kidney cancer is actively seeking new participants at 12 locations across the United States. The study is sponsored by Steba Biotech S.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04620239 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04620239 was last updated 3 weeks ago (February 4, 2026). HelloStudys verifies this status automatically.